Coya Therapeutics (COYA) Payables (2021 - 2026)
Coya Therapeutics (COYA) posted Payables of $948192.0 for Q1 2026, down 10.64% sequentially from $1.1 million in Q4 2025, and down 43.89% YoY from $1.7 million in Q1 2025.
Coya Therapeutics (COYA) Payables (2021 - 2026) Analysis & Trends
Coya Therapeutics has reported Payables for 6 years, with the latest figure at $948192.0 in Q1 2026.
- Quarterly Payables fell 43.89% year-over-year to $948192.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $948192.0 (down 43.89% YoY) and the FY2025 annual result came in at $1.1 million, down 33.18% from the prior year.
- Payables retreated to $948192.0 in Q1 2026 per COYA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Payables peaked at $1.9 million in Q2 2024 and troughed at $237579.0 in Q2 2023.
- A 5-year average of $1.1 million and a median of $1.1 million in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables jumped 692.61% in 2024, then slumped 50.54% in 2025.
- Over 5 years, Payables stood at $1.8 million in 2022, then tumbled by 36.34% to $1.2 million in 2023, then surged by 37.42% to $1.6 million in 2024, then sank by 33.18% to $1.1 million in 2025, then fell by 10.64% to $948192.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $948192.0, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | 35.57 Mn |
| 10 | Coya Therapeutics | 114.94 Mn | 71.74 Mn | - | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 948,192.00 |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 931,344.00 |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 336,722.00 |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 633,951.00 |
| Jun 30, 2023 | 237,579.00 |
| Mar 31, 2023 | 541,752.00 |
| Dec 31, 2022 | 1.82 Mn |
| Dec 31, 2021 | 857,567.00 |